Deferred Tax Assets, Valuation Allowance of Enpro Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Enpro Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Enpro Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $3,100,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Enpro Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $3,100,000 -$600,000 -16% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q4 2024 $3,700,000 +$1,000,000 +37% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q4 2023 $2,700,000 -$8,000,000 -75% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $10,700,000 +$1,800,000 +20% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $8,900,000 +$2,300,000 +35% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $6,600,000 -$1,300,000 -16% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $7,900,000 -$16,000,000 -67% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $23,900,000 -$1,800,000 -7% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q4 2017 $25,700,000 +$5,500,000 +27% 31 Dec 2017 10-K/A 02 Aug 2019 2018 FY
Q4 2016 $20,200,000 +$2,600,000 +15% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q4 2015 $17,600,000 -$2,300,000 -12% 31 Dec 2015 10-K 22 Feb 2017 2016 FY
Q4 2014 $19,900,000 +$2,300,000 +13% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q4 2013 $17,600,000 -$100,000 -0.56% 31 Dec 2013 10-K 25 Feb 2015 2014 FY
Q4 2012 $17,700,000 +$5,600,000 +46% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q4 2011 $12,100,000 +$5,200,000 +75% 31 Dec 2011 10-K 27 Feb 2013 2012 FY
Q4 2010 $6,900,000 31 Dec 2010 10-K 27 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.